好色先生

好色先生

Explore the latest content from across our publications
Join The AAN

Log In

Forgot Password?
Create New Account

Loading... please wait

2013 Annual Meeting | S22 - Stents, Lines, and Surgery for Ischemic Stroke

Wednesday 03/20/13
02:00 PM - 03:45 PM Add To Calendar
This program will be presented both in-person and online
This program is not expected to be available in the meeting's On Demand product.
Scientific Platform Session
Cerebrovascular Disease and Interventional Neurology
No CME available
Event Timeline
02:00 PM - 03:45 PM Abstract 001 - Revascularization Risk in Symptomatic Versus Asymptomatic Patients - Relative Versus Absolute Risk: The Carotid Revascularization Endarterectomy Versus Stenting Trial (CREST)
02:00 PM - 03:45 PM Abstract 002 - The Effect of Pre-Existing Atrial Fibrillation on In-Hospital Outcomes in Patients Undergoing Carotid Endarterectomy or Stent Placement in General Practice
Syeda L. Alqadri, MD
02:00 PM - 03:45 PM Abstract 003 - Risk of Brain Infarctions during Carotid Endarterectomy and Stenting - Pilot Data of a Prospective Study
02:00 PM - 03:45 PM Abstract 004 - The Prognostic Significance of Subendocardial Myocardial Infarction in Patients Undergoing Carotid Endarterectomy or Carotid Artery Stent Placement
Amir Khan, MD
02:00 PM - 03:45 PM Abstract 005 - Unusual Presentation of Mantle Cell Lymphoma Revealed by Central Nervous System Involvement: A Case Report
Geraldine Faivre, MD
02:00 PM - 03:45 PM Abstract 006 - Cost Effectiveness of Decompressive Hemicraniectomy Versus Medical Management in Patients with Malignant Ischemic Stroke
02:00 PM - 03:45 PM Abstract 007 - Stroke Related Limb Weakness Confers Thrombotic Complications with PICC Lines
Jawad F. Kirmani, MD
Faculty Disclosures
Seemant Chaturvedi, MD, FAHA, FAAN Dr. Chaturvedi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astra Zeneca. Dr. Chaturvedi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for University of Calgary. Dr. Chaturvedi has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Heart Association. Dr. Chaturvedi has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Ramar & Paradiso. Dr. Chaturvedi has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Cole, Scott, Kissane. The institution of Dr. Chaturvedi has received research support from NINDS.
Dawn O. Kleindorfer, MD, FAAN Dr. Kleindorfer has nothing to disclose.
Edgardo Cristiano, MD Dr. Cristiano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Cristiano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Cristiano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Genzyme. Dr. Cristiano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Cristiano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck.
No disclosure on file
David Skoloudik, MD, PhD No disclosure on file
Tenbit Emiru, MD No disclosure on file
Siddhart K. Mehta, MD Dr. Mehta has nothing to disclose.
Jean-Yves Delattre, MD No disclosure on file
Masaki Watanabe No disclosure on file
Virginia J. Howard, PhD The institution of Dr. Howard has received research support from NIH. The institution of an immediate family member of Dr. Howard has received research support from NIH.
Hamza I. Maqsood, MD Dr. Qureshi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for AstraZeneca.
Geraldine Faivre, MD Dr. Faivre has nothing to disclose.
Howard Feldman, MD, FAAN The institution of Dr. Feldman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arrowhead Pharmaceuticals. The institution of Dr. Feldman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novo Nordisk. The institution of Dr. Feldman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen Research & Development LLC. The institution of Dr. Feldman has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche/Banner/API. The institution of Dr. Feldman has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Tau Consortium. The institution of Dr. Feldman has received research support from US National Institute of Health NIH/NIA. The institution of Dr. Feldman has received research support from US National Institute of Health NIH/NIA. The institution of Dr. Feldman has received research support from Vivoryon Therapeutics. The institution of Dr. Feldman has received research support from US National Institute of Health NIH/NIA. The institution of Dr. Feldman has received research support from US National Institute of Health NIH/NIA. The institution of Dr. Feldman has received research support from LuMind Foundation. The institution of Dr. Feldman has received research support from US National Institute of Health NIH/NIA. The institution of Dr. Feldman has received research support from Biohaven Pharmaceuticals. The institution of Dr. Feldman has received research support from UC San Diego School of Medicine Brain Health Support Program & Sanford Institute for Empathy and Compassion. The institution of Dr. Feldman has received research support from US National Institute of Health NIH/NIA. The institution of Dr. Feldman has received research support from US National Institute of Health NIH/NIA. Dr. Feldman has received intellectual property interests from a discovery or technology relating to health care. Dr. Feldman has a non-compensated relationship as a Medical Advisory Council with Association for Frontotemporal Degeneration (AFTD) that is relevant to AAN interests or activities. Dr. Feldman has a non-compensated relationship as a International Scientific Advisory Board with Translating Research in Elder Care (TREC) that is relevant to AAN interests or activities.
Mohammad Moussavi, MD Dr. Moussavi has nothing to disclose.
Jawad F. Kirmani, MD Dr. Kirmani has nothing to disclose.
Haitham Dababneh, MD No disclosure on file
Syeda L. Alqadri, MD No disclosure on file
Muhammad F. Suri, MD Dr. Suri has nothing to disclose.
Brajesh K. Lal Brajesh K. Lal has nothing to disclose.
Saqib A. Chaudhry, MD Dr. Chaudhry has nothing to disclose.
James F. Meschia, MD, FAAN The institution of Dr. Meschia has received research support from NINDS. The institution of Dr. Meschia has received research support from NINDS.
Maurice M. Ohayon, MD, PhD, DSc The institution of Dr. Ohayon has received research support from Jazz pharmaceuticals. The institution of Dr. Ohayon has received research support from Takeda Pharmaceuticals.
Catherine Lubetzki Catherine Lubetzki has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ROCHE. Catherine Lubetzki has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MERCK SERONO. Catherine Lubetzki has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for REWIND.
Thomas G. Brott, MD, FAAN Dr. Brott has nothing to disclose.
Shahram Majidi, MD Dr. Majidi has nothing to disclose.
Amir Khan, MD No disclosure on file
Alice J. Sheffet, PhD No disclosure on file
George Howard, PhD Dr. Howard has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bayer.